Thursday, April 23, 2020

Quel surprise! More evidence emerges that hydroxychlorquine is no miracle cure for Covid-19

Subscribe to the Daily CurveFlattener. It's always free. Just enter your email address above. 

April 23, 2020 -- Today’s reporting comes to you from Buffalo, N.Y., filed by Chronicle assistant editor Cory Perla, with the able assistance of Crowley, the dog (pictured right).

And for those of you who do not have a pet, a farm sanctuary in California is offering the opportunity to invite a goat or llama to your next Zoom meeting. 

Get used to those home Zoom meetings, because even if some policy influencers are calling for individuals to return to work by the middle of May or earlier, if you are currently working at home, that recommendation probably does not include you. This article reports that some major employers say that they will likely keep their employees working at home until a vaccine is ready. 

The New York Times' health reporter notes in this podcast that the quickest a vaccine has ever been produced and approved for the public in the U.S.A. was four years, way back when the mumps vaccine was produced in the 1950s. Despite the fact that technology has advanced significantly since then, he said that making a vaccine within 18 months is “extremely optimistic."

Meanwhile, some countries, including the Netherlands, are intending to ban public events including sport and concerts, through the end of August.

Bereft of outdoor public entertainment, maybe we can just rely on our own dreams to amuse us. According to this article in National Geographic, withdrawal from our normal environments and routines may be causing us to experience more vivid dreams. Judging from Crowley's expression, he's likely experiencing this effect right now, asleep perchance to imagine the largest chicken leg in the history of the world.


COVID CHRONICLE 04/23/2020
  • A new study has looked at the risk/benefit of using hydroxychloroquine on patients with severe Covid-19, finding evidence that there were more deaths among those given the experimental treatment. The study, which has not yet been peer-reviewed, was published online in the New England Journal of Medicine (April 21, 2020). Researchers looked at 368 male patients with coronavirus infection. They found that 11% of patients receiving routine care died versus 28% of those given hydroxychloroquine. In addition, researchers found that patients who received hydroxychloroquine did not require ventilators at a different rate than those who did not receive the treatment. 
    • A case study of a 13-year-old boy found evidence that lesions on the toes and feet may be a symptom in severe cases of Covid-19. Researchers in Italy investigated the case of a boy, who was observed to have foot lesions on Mar. 8, 2020. View the full story in our video below.


STORIES CHRONICLE IS WORKING ON TODAY

A story on mothers breastfeeding while infected with Covid-19. The Canadian Pediatric Society just sent out this press release on the subject, and I am following up with the experts.

RIGHT NOW WE ARE LISTENING TO...

Ágætis Byrjun by the Icelandic band Sigur Rós. Sigur Rós's front-man, Jónsi, has just recovered from Covid-19. Watch the haunting music video for their song “Svefn-g-englar,” below.




LATER WE ARE READING...

Steppenwolf by Hermann Hesse. The longer in our quarantine, the more like a caged animal we may begin to feel -- but perhaps the animal was part of us all along. In the end, hopefully, the despair of our isolation will ultimately result in a transcendent new experience of the world. Or, at least, that's an idea inspired from reading Hesse.

TONIGHT WE ARE COOKING...

Kabobs on the grill made with chicken, not cow, since this beef plant in Alberta just shut down due to the death of a worker from Covid-19. Despite this, the grill is active for the season now, and we refuse to abandon it.

HOW IS YOUR WEEK GOING?
 

Please make use of the comments section at the Daily CurveFlattener, to let us know what you're up to today, or if you have had any particularly vivid dreams. Also, feel free to check in via LinkedIn, email, or your choice of connector. By all means, pass this newsletter along to your colleagues.

That's it. Stay in touch, stay safe. The CurveFlattener is back will a new report tomorrow from my colleague Dhiren. 

No comments:

Post a Comment

Thanks for posting a comment. Your remarks are waiting for confirmation, which may take a little while. Check back frequently